Home » Newsletters » BioWorld Asia

BioWorld Asia

March 29, 2000

View Archived Issues

Actelion Files For 1M-share IPO On Swiss New Market

Axxima completes DM20 Million Financing For Anti-Infectives

Researchers Find Hippocampi Area Of Adult Brain Can Grow

Matrix begins DO2 trial

European Court Deals Another Blow To Clarity On Biotech

Toronto Researchers Discover Gene Regulating Cancer Growth

Survey shows European skepticism over GM foods grows

Israeli Biotechnology Seen As Opportunity Not To Be Missed

Promise Of Gains In Genetic Research Raises Firm's Shares

Despite Market Falloff, Transghne Still Plans To Carry Out Offering

Peptide Therapeutics To Sell Its Drug Discovery Unit To Medivir

Scotia Talking With Possible Partners On Foscan PDT

Eurogen Moving Collar Device For Gene Delivery Into Phase I

Other News To Note

Sweden's Karo Bio In Agreement To Buy Novalon, U.S. Biotech Firm

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...